Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pergoveris vs GONAL-f in Poor Ovarian Responders (ESPART)
NCT02047227Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- Jan 2014
- Primary completion
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of luteinizing hormone in infertility, sponsored by Merck KGaA. Started Jan 2014; status: completed.
02
Drugs
luteinizing hormone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02047227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047227.